Publications

Publications from OUS - Molecular Medicine (Sioud)

104 publications found

Publications 2020

  1. Darvekar S, Juzenas P, Oksvold M, Kleinauskas A, Holien T, Christensen E, Stokke T, Sioud M, Peng Q (2020)
    Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis
    Cancers (Basel), 12 (2)
    DOI 10.3390/cancers12020377, PubMed 32041351
  2. Iversen PO, Sioud M (2020)
    Harnessing the Antiviral-Type Responses Induced by Immunostimulatory siRNAs for Cancer Immunotherapy
    Methods Mol Biol, 2115, 281-287
    DOI 10.1007/978-1-0716-0290-4_16, PubMed 32006407
  3. Mobergslien A, Sioud M (2020)
    Exploring 5'-Biotinylation of the Sense Strand to Improve siRNA Specificity and Potency
    Methods Mol Biol, 2115, 163-170
    DOI 10.1007/978-1-0716-0290-4_9, PubMed 32006400
  4. Sioud M (2020)
    Optimized siRNA Delivery into Primary Immune Cells Using Electroporation
    Methods Mol Biol, 2115, 119-131
    DOI 10.1007/978-1-0716-0290-4_7, PubMed 32006398
  5. Sioud M (2020)
    RNA and CRISPR Interferences: Past, Present, and Future Perspectives
    Methods Mol Biol, 2115, 1-22
    DOI 10.1007/978-1-0716-0290-4_1, PubMed 32006392
  6. Sioud M (2020)
    Unleashing the Therapeutic Potential of Dendritic and T Cell Therapies Using RNA Interference
    Methods Mol Biol, 2115, 259-280
    DOI 10.1007/978-1-0716-0290-4_15, PubMed 32006406
  7. Sæbøe-Larssen S, Sioud M (2020)
    Improving Dendritic Cell Cancer Vaccine Potency Using RNA Interference
    Methods Mol Biol, 2115, 249-258
    DOI 10.1007/978-1-0716-0290-4_14, PubMed 32006405
  8. Wälchli S, Sioud M (2020)
    Next Generation of Adoptive T Cell Therapy Using CRISPR/Cas9 Technology: Universal or Boosted?
    Methods Mol Biol, 2115, 407-417
    DOI 10.1007/978-1-0716-0290-4_22, PubMed 32006413

Publications 2019

  1. Sioud M (2019)
    Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics
    Mol Biotechnol, 61 (4), 286-303
    DOI 10.1007/s12033-019-00156-8, PubMed 30729435
  2. Sioud M (2019)
    Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
    Cancers (Basel), 11 (2)
    DOI 10.3390/cancers11020176, PubMed 30717461
  3. Sioud M, Pettersen S, Ailte I, Fløisand Y (2019)
    Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
    Cancers (Basel), 11 (8)
    DOI 10.3390/cancers11081088, PubMed 31370273

Publications 2018

  1. Peng W, de Bruijn HS, Farrell E, Sioud M, Mashayekhi V, Oliveira S, van Dam GM, Roodenburg JLN, Witjes MJH, Robinson DJ (2018)
    Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines
    Lasers Surg Med, 50 (5), 513-522
    DOI 10.1002/lsm.22930, PubMed 29777587
  2. Sioud M (2018)
    T-cell cross-reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors
    Scand J Immunol, 87 (3)
    DOI 10.1111/sji.12643, PubMed 29381830
  3. Sioud M, Westby P, Vasovic V, Fløisand Y, Peng Q (2018)
    Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies
    FASEB J, 32 (9), 5063-5077
    DOI 10.1096/fj.201701544R, PubMed 29913558

Publications 2016

  1. Mobergslien A, Peng Q, Vasovic V, Sioud M (2016)
    Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth
    Oncotarget, 7 (46), 75940-75953
    DOI 10.18632/oncotarget.12445, PubMed 27713158
  2. Sioud M, Nyakas M, Sæbøe-Larssen S, Mobergslien A, Aamdal S, Kvalheim G (2016)
    Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
    Case Rep Med, 2016, 9639585
    DOI 10.1155/2016/9639585, PubMed 27504122
  3. Zins K, Schäfer R, Paulus P, Dobler S, Fakhari N, Sioud M, Aharinejad S, Abraham D (2016)
    Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways
    Oncotarget, 7 (29), 46187-46202
    DOI 10.18632/oncotarget.10070, PubMed 27323822

Publications 2015

  1. Mobergslien A, Sioud M (2015)
    A facile method for interfering with off-target silencing mediated by the sense strand
    Methods Mol Biol, 1218, 293-300
    DOI 10.1007/978-1-4939-1538-5_18, PubMed 25319659
  2. Mobergslien A, Vasovic V, Mathiesen G, Fredriksen L, Westby P, Eijsink VG, Peng Q, Sioud M (2015)
    Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells
    Hum Vaccin Immunother, 11 (11), 2664-73
    DOI 10.1080/21645515.2015.1056952, PubMed 26185907
  3. Sioud M (2015)
    Cytoplasmic delivery of siRNAs to monocytes and dendritic cells via electroporation
    Methods Mol Biol, 1218, 107-15
    DOI 10.1007/978-1-4939-1538-5_6, PubMed 25319647
  4. Sioud M (2015)
    Overcoming the challenges of siRNA activation of innate immunity: design better therapeutic siRNAs
    Methods Mol Biol, 1218, 301-19
    DOI 10.1007/978-1-4939-1538-5_19, PubMed 25319660
  5. Sioud M (2015)
    Modified 2'-ribose small RNAs function as Toll-like receptor-7/8 antagonists
    Methods Mol Biol, 1218, 483-9
    DOI 10.1007/978-1-4939-1538-5_28, PubMed 25319669
  6. Sioud M (2015)
    Strategies for siRNA navigation to desired cells
    Methods Mol Biol, 1218, 201-16
    DOI 10.1007/978-1-4939-1538-5_12, PubMed 25319653
  7. Sioud M (2015)
    RNA interference: mechanisms, technical challenges, and therapeutic opportunities
    Methods Mol Biol, 1218, 1-15
    DOI 10.1007/978-1-4939-1538-5_1, PubMed 25319642
  8. Sioud M, Mobergslien A, Sæbøe-Larssen S (2015)
    Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses
    Methods Mol Biol, 1218, 269-76
    DOI 10.1007/978-1-4939-1538-5_16, PubMed 25319657
  9. Sioud M, Westby P, Olsen JK, Mobergslien A (2015)
    Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells
    Mol Ther Methods Clin Dev, 2, 15043
    DOI 10.1038/mtm.2015.43, PubMed 26605373

Publications 2014

  1. Sioud M (2014)
    Engineering better immunotherapies via RNA interference
    Hum Vaccin Immunother, 10 (11), 3165-74
    DOI 10.4161/hv.29754, PubMed 25483669

Publications 2013

  1. Mobergslien A, Sioud M (2013)
    Exosome-derived miRNAs and cellular miRNAs activate innate immunity
    J Innate Immun, 6 (1), 105-10
    DOI 10.1159/000351460, PubMed 23774807
  2. Sioud M, Saebøe-Larssen S, Hetland TE, Kaern J, Mobergslien A, Kvalheim G (2013)
    Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
    Int J Oncol, 43 (1), 280-8
    DOI 10.3892/ijo.2013.1922, PubMed 23620105
  3. Sioud M, Skorstad G, Mobergslien A, Sæbøe-Larssen S (2013)
    A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells
    FASEB J, 27 (8), 3272-83
    DOI 10.1096/fj.12-224758, PubMed 23671272

Publications 2012

  1. Sioud M, Mobergslien A (2012)
    Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides
    Bioconjug Chem, 23 (5), 1040-9
    DOI 10.1021/bc300050j, PubMed 22443209
  2. Sioud M, Mobergslien A (2012)
    Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide
    Biochem Pharmacol, 84 (9), 1123-32
    DOI 10.1016/j.bcp.2012.08.002, PubMed 22922046

Publications 2011

  1. Mobergslien A, Sioud M (2011)
    Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production
    J Leukoc Biol, 91 (3), 461-7
    DOI 10.1189/jlb.0711361, PubMed 22167721
  2. Sioud M (2011)
    New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins
    Scand J Immunol, 73 (2), 79-84
    DOI 10.1111/j.1365-3083.2010.02491.x, PubMed 21198747
  3. Sioud M (2011)
    Promises and challenges in developing RNAi as a research tool and therapy
    Methods Mol Biol, 703, 173-87
    DOI 10.1007/978-1-59745-248-9_12, PubMed 21125490

Publications 2010

  1. Mobergslien A, Sioud M (2010)
    Optimized protocols for siRNA delivery into monocytes and dendritic cells
    Methods Mol Biol, 629, 71-85
    DOI 10.1007/978-1-60761-657-3_5, PubMed 20387143
  2. Sioud M (2010)
    RNA therapeutics: function, design, and delivery. Preface
    Methods Mol Biol, 629, v-vii
    DOI 10.1007/978-1-60761-657-3, PubMed 20394129
  3. Sioud M (2010)
    Advances in RNA sensing by the immune system: separation of siRNA unwanted effects from RNA interference
    Methods Mol Biol, 629, 33-52
    DOI 10.1007/978-1-60761-657-3_3, PubMed 20387141
  4. Sioud M (2010)
    Development of TLR7/8 small RNA antagonists
    Methods Mol Biol, 629, 387-94
    DOI 10.1007/978-1-60761-657-3_25, PubMed 20387163
  5. Sioud M (2010)
    Modulation of dendritic cell maturation and function by siRNA-bearing 5'-triphosphate
    Methods Mol Biol, 629, 395-404
    DOI 10.1007/978-1-60761-657-3_26, PubMed 20387164
  6. Sioud M (2010)
    Recent advances in small interfering RNA sensing by the immune system
    N Biotechnol, 27 (3), 236-42
    DOI 10.1016/j.nbt.2010.02.015, PubMed 20219711
  7. Sioud M (2010)
    What are the key targeted delivery technologies of siRNA now?
    Methods Mol Biol, 629, 93-107
    DOI 10.1007/978-1-60761-657-3_7, PubMed 20387145
  8. Sioud M (2010)
    Overcoming self-tolerance to tumour cells
    Methods Mol Biol, 629, 495-505
    DOI 10.1007/978-1-60761-657-3_29, PubMed 20387167
  9. Sioud M, Cekaite L (2010)
    Profiling of miRNA expression and prediction of target genes
    Methods Mol Biol, 629, 257-71
    DOI 10.1007/978-1-60761-657-3_16, PubMed 20387154
  10. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
    Scand J Immunol, 71 (4), 267-74
    DOI 10.1111/j.1365-3083.2010.02378.x, PubMed 20384870
  11. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
    Int J Oncol, 38 (2), 385-90
    DOI 10.3892/ijo.2010.869, PubMed 21165555

Publications 2009

  1. Sioud M (2009)
    Deciphering the code of innate immunity recognition of siRNAs
    Methods Mol Biol, 487, 41-59
    DOI 10.1007/978-1-60327-547-7_2, PubMed 19301641
  2. Sioud M (2009)
    Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells
    Methods Mol Biol, 487, 61-82
    DOI 10.1007/978-1-60327-547-7_3, PubMed 19301642
  3. Sioud M (2009)
    Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
    Scand J Immunol, 70 (6), 516-25
    DOI 10.1111/j.1365-3083.2009.02326.x, PubMed 19906192
  4. Sioud M, Boudabous A, Cekaite L (2009)
    Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti-tumour drugs
    Int J Mol Med, 23 (1), 33-9
    DOI 10.3892/ijmm_00000098, PubMed 19082504
  5. Sioud M, Fløisand Y (2009)
    NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation
    J Leukoc Biol, 85 (6), 939-46
    DOI 10.1189/jlb.1008650, PubMed 19244164
  6. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    DOI 10.1111/j.1365-3083.2008.02223.x, PubMed 19284496

Publications 2008

  1. Maturana AD, Wälchli S, Iwata M, Ryser S, Van Lint J, Hoshijima M, Schlegel W, Ikeda Y, Tanizawa K, Kuroda S (2008)
    Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel
    Cardiovasc Res, 78 (3), 458-65
    DOI 10.1093/cvr/cvn052, PubMed 18296710
  2. Nygren MK, Døsen-Dahl G, Stubberud H, Wälchli S, Munthe E, Rian E (2008)
    beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells
    Exp Hematol, 37 (2), 225-33
    DOI 10.1016/j.exphem.2008.10.007, PubMed 19101069
  3. Sioud M (2008)
    Does the understanding of immune activation by RNA predict the design of safe siRNAs?
    Front Biosci, 13, 4379-92
    DOI 10.2741/3011, PubMed 18508517
  4. Sioud M, Cekaite L (2008)
    Expression profiling of microRNAs in cancer cells: technical considerations
    Methods Mol Biol, 439, 179-90
    DOI 10.1007/978-1-59745-188-8_12, PubMed 18370103
  5. Walchli S, Sioud M (2008)
    Vector-based delivery of siRNAs: in vitro and in vivo challenges
    Front Biosci, 13, 3488-93
    DOI 10.2741/2943, PubMed 18508450

Publications 2007

  1. Sioud M (2007)
    RNA interference and innate immunity
    Adv Drug Deliv Rev, 59 (2-3), 153-63
    DOI 10.1016/j.addr.2007.03.006, PubMed 17459518
  2. Sioud M (2007)
    Main approaches to target discovery and validation
    Methods Mol Biol, 360, 1-12
    DOI 10.1385/1-59745-165-7:1, PubMed 17172722
  3. Sioud M (2007)
    An overview of the immune system and technical advances in tumor antigen discovery and validation
    Methods Mol Biol, 360, 277-318
    DOI 10.1385/1-59745-165-7:277, PubMed 17172735
  4. Sioud M, Fløisand Y (2007)
    TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
    Eur J Immunol, 37 (10), 2834-46
    DOI 10.1002/eji.200737112, PubMed 17853407
  5. Sioud M, Furset G, Cekaite L (2007)
    Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs
    Biochem Biophys Res Commun, 361 (1), 122-6
    DOI 10.1016/j.bbrc.2007.06.177, PubMed 17658482
  6. Sioud M, Leirdal M (2007)
    Druggable signaling proteins
    Methods Mol Biol, 361, 1-24
    DOI 10.1385/1-59745-208-4:1, PubMed 17172705
  7. Sioud M, Melien O (2007)
    Treatment options and individualized medicine
    Methods Mol Biol, 361, 327-40
    DOI 10.1385/1-59745-208-4:327, PubMed 17172721

Publications 2006

  1. Sioud M (2006)
    RNA interference below the immune radar
    Nat Biotechnol, 24 (5), 521-2
    DOI 10.1038/nbt0506-521, PubMed 16680132
  2. Sioud M (2006)
    RNAi therapy: antibodies guide the way
    Gene Ther, 13 (3), 194-5
    DOI 10.1038/sj.gt.3302634, PubMed 17243203
  3. Sioud M (2006)
    Innate sensing of self and non-self RNAs by Toll-like receptors
    Trends Mol Med, 12 (4), 167-76
    DOI 10.1016/j.molmed.2006.02.004, PubMed 16530484
  4. Sioud M (2006)
    Ribozymes and siRnas: from structure to preclinical applications
    Handb Exp Pharmacol (173), 223-42
    DOI 10.1007/3-540-27262-3_11, PubMed 16594618
  5. Sioud M (2006)
    Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses
    Eur J Immunol, 36 (5), 1222-30
    DOI 10.1002/eji.200535708, PubMed 16609928
  6. Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
    Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
    J Mol Biol, 364 (5), 945-54
    DOI 10.1016/j.jmb.2006.09.054, PubMed 17049554
  7. Sioud M, Furset G (2006)
    Molecular basis for the immunostimulatory potency of small interfering RNAs
    J Biomed Biotechnol, 2006 (4), 23429
    DOI 10.1155/JBB/2006/23429, PubMed 17057361
  8. Sioud M, Haoudi A (2006)
    RNA interference
    J Biomed Biotechnol, 2006 (4), 89018
    DOI 10.1155/JBB/2006/89018, PubMed 17057373

Publications 2005

  1. Røsok O, Sioud M (2005)
    Systematic search for natural antisense transcripts in eukaryotes (review)
    Int J Mol Med, 15 (2), 197-203
    PubMed 15647831
  2. Sioud M (2005)
    On the delivery of small interfering RNAs into mammalian cells
    Expert Opin Drug Deliv, 2 (4), 639-51
    DOI 10.1517/17425247.2.4.639, PubMed 16296791
  3. Sioud M (2005)
    siRNA delivery in vivo
    Methods Mol Biol, 309, 237-49
    DOI 10.1385/1-59259-935-4:237, PubMed 15990404
  4. Sioud M (2005)
    Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
    J Mol Biol, 348 (5), 1079-90
    DOI 10.1016/j.jmb.2005.03.013, PubMed 15854645
  5. Sioud M, Iversen PO (2005)
    Ribozymes, DNAzymes and small interfering RNAs as therapeutics
    Curr Drug Targets, 6 (6), 647-53
    DOI 10.2174/1389450054863653, PubMed 16178798
  6. Sioud M, Røsok Ø (2005)
    High-throughput analysis of microRNA gene expression using sensitive probes
    Methods Mol Biol, 309, 311-20
    DOI 10.1385/1-59259-935-4:311, PubMed 15990410
  7. Sioud M, Wälchli S (2005)
    Strategies for the design of random siRNA libraries and the selection of anti-GFP siRNAs
    Methods Mol Biol, 309, 83-91
    DOI 10.1385/1-59259-935-4:083, PubMed 15990399

Publications 2004

  1. Hirschberg H, Madsen S, Angell-Petersen E, Peng Q, Sioud M, Sun CH, Sorensen DR (2004)
    Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma
    P SOC PHOTO-OPT INS, 5312, 405-414
  2. Røsok O, Sioud M (2004)
    An experimental approach for systematic identification of antisense transcripts
    Discov Med, 4 (20), 58-60
    PubMed 20705023
  3. Sioud M (2004)
    Therapeutic siRNAs
    Trends Pharmacol Sci, 25 (1), 22-8
    DOI 10.1016/j.tips.2003.11.006, PubMed 14723975
  4. Sioud M (2004)
    Therapeutic potential of small interfering RNAs
    Drug Future, 29 (7), 741-750
  5. Sioud M (2004)
    Ribozyme- and siRNA-mediated mRNA degradation: a general introduction
    Methods Mol Biol, 252, 1-8
    DOI 10.1385/1-59259-746-7:001, PubMed 15017038
  6. Sioud M, Leirdal M (2004)
    Potential design rules and enzymatic synthesis of siRNAs
    Methods Mol Biol, 252, 457-69
    DOI 10.1385/1-59259-746-7:457, PubMed 15017071
  7. Sioud M, Røsok O (2004)
    Profiling microRNA expression using sensitive cDNA probes and filter arrays
    Biotechniques, 37 (4), 574-6, 578-80
    DOI 10.2144/04374ST01, PubMed 15517969
  8. Sioud M, Sørensen DR (2004)
    Systemic delivery of synthetic siRNAs
    Methods Mol Biol, 252, 515-22
    DOI 10.1385/1-59259-746-7:515, PubMed 15017077

Publications 2003

  1. Røsok Ø, Sioud M (2003)
    Systematic identification of sense-antisense transcripts in mammalian cells
    Nat Biotechnol, 22 (1), 104-8
    DOI 10.1038/nbt925, PubMed 14704709
  2. Sioud M, Sørensen D (2003)
    Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens
    Eur J Immunol, 33 (1), 38-45
    DOI 10.1002/immu.200390005, PubMed 12594830
  3. Sioud M, Sørensen DR (2003)
    Cationic liposome-mediated delivery of siRNAs in adult mice
    Biochem Biophys Res Commun, 312 (4), 1220-5
    DOI 10.1016/j.bbrc.2003.11.057, PubMed 14652004

Publications 2002

  1. Sioud M (2002)
    How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry
    Mol Med, 8 (3), 115-9
    DOI 10.1007/BF03402004, PubMed 12142543

Publications 2001

  1. Sioud M (2001)
    Nucleic acid enzymes as a novel generation of anti-gene agents
    Curr Mol Med, 1 (5), 575-88
    DOI 10.2174/1566524013363366, PubMed 11899232
  2. Sioud M, Hansen MH (2001)
    Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries
    Eur J Immunol, 31 (3), 716-25
    DOI 10.1002/1521-4141(200103)31:3<716::aid-immu716>3.0.co;2-9, PubMed 11241275

Publications 2000

  1. Røsok O, Pedeutour F, Odeberg J, Lundeberg J, Aasheim HC (2000)
    The C1orf9 gene encodes a putative transmembrane member of a novel protein family
    Biochem Biophys Res Commun, 267 (3), 855-62
    DOI 10.1006/bbrc.1999.2016, PubMed 10673381
  2. Sioud M, Hansen M, Dybwad A (2000)
    Profiling the immune responses in patient sera with peptide and cDNA display libraries
    Int J Mol Med, 6 (2), 123-8
    DOI 10.3892/ijmm.6.2.123, PubMed 10891554
  3. Sioud M, Leirdal M (2000)
    Therapeutic RNA and DNA enzymes
    Biochem Pharmacol, 60 (8), 1023-6
    DOI 10.1016/s0006-2952(00)00395-6, PubMed 11007937
  4. Sioud M, Leirdal M (2000)
    Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application
    J Mol Biol, 296 (3), 937-47
    DOI 10.1006/jmbi.2000.3491, PubMed 10677293

Publications 1999

  1. Røsok O, Pedeutour F, Ree AH, Aasheim HC (1999)
    Identification and characterization of TESK2, a novel member of the LIMK/TESK family of protein kinases, predominantly expressed in testis
    Genomics, 61 (1), 44-54
    DOI 10.1006/geno.1999.5922, PubMed 10512679
  2. Sioud M (1999)
    Application of preformed hammerhead ribozymes in the gene therapy of cancer (review)
    Int J Mol Med, 3 (4), 381-4
    DOI 10.3892/ijmm.3.4.381, PubMed 10085409
  3. Sioud M, Leirdal M (1999)
    Substitution of the 2'-hydroxyl group at position 2.1 by an amino group interferes with Mg(2+) binding and efficient cleavage by hammerhead ribozyme
    Biochem Biophys Res Commun, 262 (2), 461-6
    DOI 10.1006/bbrc.1999.1236, PubMed 10462497

Publications 1998

  1. Sioud M, Sørensen DR (1998)
    A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth
    Nat Biotechnol, 16 (6), 556-61
    DOI 10.1038/nbt0698-556, PubMed 9624687

Publications 1996

  1. Røsok O, Odeberg J, Rode M, Stokke T, Funderud S, Smeland E, Lundeberg J (1996)
    Solid-phase method for differential display of genes expressed in hematopoietic stem cells
    Biotechniques, 21 (1), 114-21
    DOI 10.2144/96211rr02, PubMed 8816245

Publications 1994

  1. NATVIG JB, WILSON KB, QUAYLE A, SULEYMAN S, KJELDSENKRAGH J, FORRE O, SIOUD M, CAPRA JD (1994)
    T-CELL RECEPTOR VARIABLE GENE REPERTOIRE IN RHEUMATOID SYNOVIAL T-CELLS RESPONDING TO BCG
    NATO ADV SCI INST SE, 80, 191-196

Publications 1986

  1. Bernard M, Sioud M, Percheron F, Foglietti MJ (1986)
    beta-Mannosidase in human serum and urine. A comparative study
    Int J Biochem, 18 (11), 1065-8
    DOI 10.1016/0020-711x(86)90255-7, PubMed 3803698
 
Page visits: 6160